• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Epidemiol Early SNS-based Monitoring System for the COVID-19 Outbreak in Japan: A Population-Level Observational Study

tetano

Editor, Senior Moderator
J Epidemiol


. 2020 May 30.
doi: 10.2188/jea.JE20200150. Online ahead of print.
Early SNS-based Monitoring System for the COVID-19 Outbreak in Japan: A Population-Level Observational Study


Daisuke Yoneoka[SUP] 1 2 3 [/SUP], Takayuki Kawashima[SUP] 4 [/SUP], Yuta Tanoue[SUP] 5 [/SUP], Shuhei Nomura[SUP] 1 3 [/SUP], Keisuke Ejima[SUP] 6 [/SUP], Shoi Shi[SUP] 7 8 [/SUP], Akifumi Eguchi[SUP] 9 [/SUP], Toshibumi Taniguchi[SUP] 10 [/SUP], Haruka Sakamoto[SUP] 1 3 [/SUP], Hiroyuki Kunishima[SUP] 11 [/SUP], Stuart Gilmour[SUP] 2 [/SUP], Hiroshi Nishiura[SUP] 12 [/SUP], Hiroaki Miyata[SUP] 1 [/SUP]



Affiliations
Free article

Abstract

BackgroundThe World Health Organization declared the novel coronavirus outbreak (COVID-19) to be a pandemic on March 11, 2020. Large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan would improve preparation for and prevention of a massive outbreak.MethodsA chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smart prevention And care seeking) was developed using the LINE app to evaluate the current Japanese epidemiological situation. LINE users could participate in the system either though a QR code page in the prefecture's website, or a banner at the top of the LINE app screen. COOPERA asked participants questions regarding personal information, preventive actions, and non-specific symptoms related to COVID-19 and their duration. We calculated daily cross correlation functions between the reported number of infected cases confirmed by PCR and the symptom-positive group captured by COOPERA.ResultsWe analyzed 206,218 participants from three prefectures reported between March 5 and 30, 2020. The mean (standard deviation) age of participants was 44.2 (13.2). No symptoms were reported by 96.93% of participants, but there was a significantly positive correlation between the reported number of COVID-19 cases and self-reported fevers, suggesting that massive monitoring of fever might help to estimate the scale of the COVID-19 epidemic in real time.ConclusionsCOOPERA is the first real-time system being used to monitor trends in COVID-19 in Japan, and provides useful insights to assist political decisions to tackle the epidemic.

Keywords: COVID-19; Japan; Large-scale monitoring system.
 
Back
Top Bottom